Skip to main content
. 2020 Dec 23;22(1):88. doi: 10.3390/ijms22010088
NS nephrotic syndrome
MCNS minimal change nephrotic syndrome
FSGS focal segmental glomerulosclerosis
MGN membranous glomerulonephropathy
suPAR soluble form of the urokinase receptor
miRNA microRNA
3′-UTR three prime untranslated region
PLA2R1 phospholipase A2 receptor 1
THSD7A thrombospondin type-1 domain-containing 7A
NELL-1 neural epidermal growth factor-like 1 protein
TNFSF11 TNF superfamily member 11
JNK c-Jun N-terminal kinase
LPS lipopolysaccharide
IL-13 interleukin 13
Angptl-4 angiopoietin-like 4
uPAR urokinase plasminogen activator receptor
PAN puromycin aminonucleoside
TRPC1 transient receptor potential canonical 1
DN diabetes nephropathy
PTEN phosphatase and tensin homolog
BCL2L11 Bcl-2-like protein 11
CXCL14 C-X-C motif chemokine ligand 14
WT1 Wilms’ tumor protein
TRPC6 transient receptor potential cation channel subfamily C member 6
PPP3CA protein phosphatase 3 catalytic subunit alpha
PPP3CB protein phosphatase 3 catalytic subunit beta
PPP3R1 protein phosphatase 3 regulatory subunit alpha
NFATC3 nuclear factor of activated T cells 3
ITGB3 integrin β3
BNIP3L BCL2 interacting protein 3 like
NOS not otherwise specified